Accelerated and increased joint damage in young mice with global inactivation of mitogen-inducible gene 6 after ligament and meniscus injury

Ligament and meniscal damage can cause joint disease. Arthritic joints contain increased amounts of epidermal growth factor receptor (EGFR) protein, and polymorphisms in EGFR are associated with arthritis risk. The role of endogenous EGFR regulation during joint disease due to ligament and meniscal...

Full description

Saved in:
Bibliographic Details
Published inArthritis research & therapy Vol. 16; no. 2; p. R81
Main Authors Joiner, Danese M, Less, Kennen D, Van Wieren, Emily M, Zhang, Yu-Wen, Hess, Daniel, Williams, Bart O
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 27.03.2014
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Ligament and meniscal damage can cause joint disease. Arthritic joints contain increased amounts of epidermal growth factor receptor (EGFR) protein, and polymorphisms in EGFR are associated with arthritis risk. The role of endogenous EGFR regulation during joint disease due to ligament and meniscal trauma is unknown. Mitogen-inducible gene 6 (MIG-6) can reduce EGFR phosphorylation and downstream signaling. We examined the effect of EGFR modulation by MIG-6 on joint disease development after ligament and meniscus injury. Knee ligament transection and meniscus removal were performed surgically on mice homozygous for a global inactivating mutation in MIG-6 (Mig-6⁻/⁻) and in wild-type (WT) animals. Two weeks after surgery, Mig-6⁻/⁻mice had bone erosion as well as greater fibrous tissue area and serum RANKL concentration than WT mice. Four weeks after surgery, Mig-6⁻/⁻mice had less cartilage and increased cell proliferation relative to contralateral control and WT knees. Increased apoptotic cells and growth outside the articulating region occurred in Mig-6⁻/⁻mice. Tibia trabecular bone mineral density (BMD) and the number of trabeculae were lower in surgically treated knees relative to the respective control knees for both groups. BMD, as well as trabecular thickness and number, were lower in surgically treated knees from Mig-6⁻/⁻mice relative to WT surgically treated knees. Phosphorylated EGFR staining in surgically treated knees decreased for WT mice and increased for Mig-6⁻/⁻mice. Fewer inflammatory cells were present in the knees of WT mice. Mig-6⁻/⁻mice have rapid and increased joint damage after ligament and meniscal trauma. Mig-6 modification could lessen degenerative disease development after this type of injury.
AbstractList Introduction Ligament and meniscal damage can cause joint disease. Arthritic joints contain increased amounts of epidermal growth factor receptor (EGFR) protein, and polymorphisms in EGFR are associated with arthritis risk. The role of endogenous EGFR regulation during joint disease due to ligament and meniscal trauma is unknown. Mitogen-inducible gene 6 (MIG-6) can reduce EGFR phosphorylation and downstream signaling. We examined the effect of EGFR modulation by MIG-6 on joint disease development after ligament and meniscus injury. Methods Knee ligament transection and meniscus removal were performed surgically on mice homozygous for a global inactivating mutation in MIG-6 (Mig-6.sup.-/-) and in wild-type (WT) animals. Results Two weeks after surgery, Mig-6.sup.-/-mice had bone erosion as well as greater fibrous tissue area and serum RANKL concentration than WT mice. Four weeks after surgery, Mig-6.sup.-/-mice had less cartilage and increased cell proliferation relative to contralateral control and WT knees. Increased apoptotic cells and growth outside the articulating region occurred in Mig-6.sup.-/-mice. Tibia trabecular bone mineral density (BMD) and the number of trabeculae were lower in surgically treated knees relative to the respective control knees for both groups. BMD, as well as trabecular thickness and number, were lower in surgically treated knees from Mig-6.sup.-/-mice relative to WT surgically treated knees. Phosphorylated EGFR staining in surgically treated knees decreased for WT mice and increased for Mig-6.sup.-/-mice. Fewer inflammatory cells were present in the knees of WT mice. Conclusion Mig-6.sup.-/-mice have rapid and increased joint damage after ligament and meniscal trauma. Mig-6 modification could lessen degenerative disease development after this type of injury.
INTRODUCTIONLigament and meniscal damage can cause joint disease. Arthritic joints contain increased amounts of epidermal growth factor receptor (EGFR) protein, and polymorphisms in EGFR are associated with arthritis risk. The role of endogenous EGFR regulation during joint disease due to ligament and meniscal trauma is unknown. Mitogen-inducible gene 6 (MIG-6) can reduce EGFR phosphorylation and downstream signaling. We examined the effect of EGFR modulation by MIG-6 on joint disease development after ligament and meniscus injury. METHODSKnee ligament transection and meniscus removal were performed surgically on mice homozygous for a global inactivating mutation in MIG-6 (Mig-6⁻/⁻) and in wild-type (WT) animals. RESULTSTwo weeks after surgery, Mig-6⁻/⁻mice had bone erosion as well as greater fibrous tissue area and serum RANKL concentration than WT mice. Four weeks after surgery, Mig-6⁻/⁻mice had less cartilage and increased cell proliferation relative to contralateral control and WT knees. Increased apoptotic cells and growth outside the articulating region occurred in Mig-6⁻/⁻mice. Tibia trabecular bone mineral density (BMD) and the number of trabeculae were lower in surgically treated knees relative to the respective control knees for both groups. BMD, as well as trabecular thickness and number, were lower in surgically treated knees from Mig-6⁻/⁻mice relative to WT surgically treated knees. Phosphorylated EGFR staining in surgically treated knees decreased for WT mice and increased for Mig-6⁻/⁻mice. Fewer inflammatory cells were present in the knees of WT mice. CONCLUSIONMig-6⁻/⁻mice have rapid and increased joint damage after ligament and meniscal trauma. Mig-6 modification could lessen degenerative disease development after this type of injury.
INTRODUCTION: Ligament and meniscal damage can cause joint disease. Arthritic joints contain increased amounts of epidermal growth factor receptor (EGFR) protein, and polymorphisms in EGFR are associated with arthritis risk. The role of endogenous EGFR regulation during joint disease due to ligament and meniscal trauma is unknown. Mitogen-inducible gene 6 (MIG-6) can reduce EGFR phosphorylation and downstream signaling. We examined the effect of EGFR modulation by MIG-6 on joint disease development after ligament and meniscus injury. METHODS: Knee ligament transection and meniscus removal were performed surgically on mice homozygous for a global inactivating mutation in MIG-6 (Mig-6−/−) and in wild-type (WT) animals. RESULTS: Two weeks after surgery, Mig-6−/−mice had bone erosion as well as greater fibrous tissue area and serum RANKL concentration than WT mice. Four weeks after surgery, Mig-6−/−mice had less cartilage and increased cell proliferation relative to contralateral control and WT knees. Increased apoptotic cells and growth outside the articulating region occurred in Mig-6−/−mice. Tibia trabecular bone mineral density (BMD) and the number of trabeculae were lower in surgically treated knees relative to the respective control knees for both groups. BMD, as well as trabecular thickness and number, were lower in surgically treated knees from Mig-6−/−mice relative to WT surgically treated knees. Phosphorylated EGFR staining in surgically treated knees decreased for WT mice and increased for Mig-6−/−mice. Fewer inflammatory cells were present in the knees of WT mice. CONCLUSION: Mig-6−/−mice have rapid and increased joint damage after ligament and meniscal trauma. Mig-6 modification could lessen degenerative disease development after this type of injury.
Ligament and meniscal damage can cause joint disease. Arthritic joints contain increased amounts of epidermal growth factor receptor (EGFR) protein, and polymorphisms in EGFR are associated with arthritis risk. The role of endogenous EGFR regulation during joint disease due to ligament and meniscal trauma is unknown. Mitogen-inducible gene 6 (MIG-6) can reduce EGFR phosphorylation and downstream signaling. We examined the effect of EGFR modulation by MIG-6 on joint disease development after ligament and meniscus injury. Knee ligament transection and meniscus removal were performed surgically on mice homozygous for a global inactivating mutation in MIG-6 (Mig-6⁻/⁻) and in wild-type (WT) animals. Two weeks after surgery, Mig-6⁻/⁻mice had bone erosion as well as greater fibrous tissue area and serum RANKL concentration than WT mice. Four weeks after surgery, Mig-6⁻/⁻mice had less cartilage and increased cell proliferation relative to contralateral control and WT knees. Increased apoptotic cells and growth outside the articulating region occurred in Mig-6⁻/⁻mice. Tibia trabecular bone mineral density (BMD) and the number of trabeculae were lower in surgically treated knees relative to the respective control knees for both groups. BMD, as well as trabecular thickness and number, were lower in surgically treated knees from Mig-6⁻/⁻mice relative to WT surgically treated knees. Phosphorylated EGFR staining in surgically treated knees decreased for WT mice and increased for Mig-6⁻/⁻mice. Fewer inflammatory cells were present in the knees of WT mice. Mig-6⁻/⁻mice have rapid and increased joint damage after ligament and meniscal trauma. Mig-6 modification could lessen degenerative disease development after this type of injury.
Ligament and meniscal damage can cause joint disease. Arthritic joints contain increased amounts of epidermal growth factor receptor (EGFR) protein, and polymorphisms in EGFR are associated with arthritis risk. The role of endogenous EGFR regulation during joint disease due to ligament and meniscal trauma is unknown. Mitogen-inducible gene 6 (MIG-6) can reduce EGFR phosphorylation and downstream signaling. We examined the effect of EGFR modulation by MIG-6 on joint disease development after ligament and meniscus injury. Knee ligament transection and meniscus removal were performed surgically on mice homozygous for a global inactivating mutation in MIG-6 (Mig-6.sup.-/-) and in wild-type (WT) animals. Two weeks after surgery, Mig-6.sup.-/-mice had bone erosion as well as greater fibrous tissue area and serum RANKL concentration than WT mice. Four weeks after surgery, Mig-6.sup.-/-mice had less cartilage and increased cell proliferation relative to contralateral control and WT knees. Increased apoptotic cells and growth outside the articulating region occurred in Mig-6.sup.-/-mice. Tibia trabecular bone mineral density (BMD) and the number of trabeculae were lower in surgically treated knees relative to the respective control knees for both groups. BMD, as well as trabecular thickness and number, were lower in surgically treated knees from Mig-6.sup.-/-mice relative to WT surgically treated knees. Phosphorylated EGFR staining in surgically treated knees decreased for WT mice and increased for Mig-6.sup.-/-mice. Fewer inflammatory cells were present in the knees of WT mice. Mig-6.sup.-/-mice have rapid and increased joint damage after ligament and meniscal trauma. Mig-6 modification could lessen degenerative disease development after this type of injury.
Abstract Introduction Ligament and meniscal damage can cause joint disease. Arthritic joints contain increased amounts of epidermal growth factor receptor (EGFR) protein, and polymorphisms in EGFR are associated with arthritis risk. The role of endogenous EGFR regulation during joint disease due to ligament and meniscal trauma is unknown. Mitogen-inducible gene 6 ( MIG-6 ) can reduce EGFR phosphorylation and downstream signaling. We examined the effect of EGFR modulation by MIG-6 on joint disease development after ligament and meniscus injury. Methods Knee ligament transection and meniscus removal were performed surgically on mice homozygous for a global inactivating mutation in MIG-6 ( Mig-6 −/− ) and in wild-type (WT) animals. Results Two weeks after surgery, Mig-6 −/− mice had bone erosion as well as greater fibrous tissue area and serum RANKL concentration than WT mice. Four weeks after surgery, Mig-6 −/− mice had less cartilage and increased cell proliferation relative to contralateral control and WT knees. Increased apoptotic cells and growth outside the articulating region occurred in Mig-6 −/− mice. Tibia trabecular bone mineral density (BMD) and the number of trabeculae were lower in surgically treated knees relative to the respective control knees for both groups. BMD, as well as trabecular thickness and number, were lower in surgically treated knees from Mig-6 −/− mice relative to WT surgically treated knees. Phosphorylated EGFR staining in surgically treated knees decreased for WT mice and increased for Mig-6 −/− mice. Fewer inflammatory cells were present in the knees of WT mice. Conclusion Mig-6 −/− mice have rapid and increased joint damage after ligament and meniscal trauma. Mig-6 modification could lessen degenerative disease development after this type of injury.
ArticleNumber R81
Audience Academic
Author Williams, Bart O
Hess, Daniel
Less, Kennen D
Zhang, Yu-Wen
Joiner, Danese M
Van Wieren, Emily M
AuthorAffiliation 3 Michigan State University College of Human Medicine, 15 Michigan Street NE, Grand Rapids, MI 49503, USA
2 Center for Cancer and Cell Biology, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA
1 Center for Skeletal Disease and Tumor Metastasis, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA
4 Division of Pulmonary & Critical Care Medicine, University of Michigan, Biomedical Science Research Building, 109 Zina Pitcher Place Room 4062, Ann Arbor, MI 48109-2200, USA
AuthorAffiliation_xml – name: 4 Division of Pulmonary & Critical Care Medicine, University of Michigan, Biomedical Science Research Building, 109 Zina Pitcher Place Room 4062, Ann Arbor, MI 48109-2200, USA
– name: 3 Michigan State University College of Human Medicine, 15 Michigan Street NE, Grand Rapids, MI 49503, USA
– name: 2 Center for Cancer and Cell Biology, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA
– name: 1 Center for Skeletal Disease and Tumor Metastasis, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA
Author_xml – sequence: 1
  givenname: Danese M
  surname: Joiner
  fullname: Joiner, Danese M
– sequence: 2
  givenname: Kennen D
  surname: Less
  fullname: Less, Kennen D
– sequence: 3
  givenname: Emily M
  surname: Van Wieren
  fullname: Van Wieren, Emily M
– sequence: 4
  givenname: Yu-Wen
  surname: Zhang
  fullname: Zhang, Yu-Wen
– sequence: 5
  givenname: Daniel
  surname: Hess
  fullname: Hess, Daniel
– sequence: 6
  givenname: Bart O
  surname: Williams
  fullname: Williams, Bart O
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24670222$$D View this record in MEDLINE/PubMed
BookMark eNp1UltrFTEQDlKxF_UnSEAQX7bmupcX4VDUFgq-6HOYTWa3OewmNbvbcv6DP9octh49oORhbt98M5mZc3ISYkBCXnN2yXldfoCktBDPyBlXVV2UshQnB12rU3I-TVvGhGiEekFOhSqrbIgz8nNjLQ6YYEZHITjqg00IU7a20YeZOhihx-ymu7iEno7eIn308x3th9jCkCNgZ_8As4-Bxi4D5thjKHxwi_XtgDRbSEsK3YyJDr6HETPxvlhW_GSXKZNsl7R7SZ53MEz46klekO-fP327ui5uv365udrcFq2q5VwgdkpK7irHsVIlSs1LK1lbNxWA5AJqqFE12qnWCmSuayshVO04A8ek1vKCfFx575d2RGdzOwkGc5_8CGlnInhzHAn-zvTxwShWMiHrTNCsBK2P_yE4jtg4mnVFOff9U_EUfyw4zWbMM8BhgIBxmQzXutZCNk2VoW9XaA8DGh-6mMnsHm42WrFaSiX2v7n8Byo_h3lZ-Uw6n_1HCe_WBJviNCXsDo1zZvbX9KfVN3_P6QD7fT7yF6TqydU
CitedBy_id crossref_primary_10_1186_s13075_020_02213_z
crossref_primary_10_1038_celldisc_2016_50
crossref_primary_10_1186_s12967_019_1886_3
crossref_primary_10_1097_BRS_0000000000003011
crossref_primary_10_1038_srep30434
crossref_primary_10_1007_s11926_015_0524_1
crossref_primary_10_1002_art_38758
crossref_primary_10_1002_jor_23343
crossref_primary_10_1016_j_jcyt_2016_02_001
crossref_primary_10_1073_pnas_1708161114
crossref_primary_10_1002_jbm4_10177
crossref_primary_10_3390_cells10071574
Cites_doi 10.1186/ar2592
10.1038/labinvest.2009.111
10.1016/j.knee.2008.11.004
10.1016/j.joca.2005.07.014
10.1038/nature05998
10.1002/dvdy.21501
10.1002/jor.20760
10.1080/03009740510017715
10.1016/j.bone.2011.11.030
10.1074/jbc.M111.294470
10.1002/art.23885
10.1038/emm.2007.41
10.1016/j.bone.2012.02.012
10.4049/jimmunol.1102693
10.1016/j.bbrc.2005.04.144
10.1002/art.34453
10.1016/j.devcel.2012.08.001
10.1210/er.2006-0049
10.1210/me.2012-1174
10.1152/ajpcell.00379.2012
10.1158/0008-5472.CAN-04-1905
10.1038/nrm1962
10.1073/pnas.0505171102
10.1016/j.joca.2005.03.004
10.1002/jbmr.295
10.1016/j.bone.2012.04.012
10.1172/JCI18358
10.3109/03008200903427695
10.1196/annals.1402.019
10.1016/j.tem.2009.06.008
10.1002/jbmr.502
10.1007/s00296-011-1961-4
10.1007/s11999-009-0751-8
10.1016/j.jbiomech.2009.05.034
10.1074/jbc.M909735199
10.1242/dev.032979
10.1016/j.proghi.2006.02.003
10.1016/j.rdc.2008.07.001
10.1242/dev.00664
10.1016/j.joca.2013.05.019
10.4161/cc.6.5.3928
10.1016/j.joca.2012.01.022
10.1002/jcp.21511
10.2174/157339712802083795
10.1002/art.22968
10.1371/journal.pone.0059798
10.1016/j.joca.2011.06.007
10.1002/1529-0131(200010)43:10<2143::AID-ANR1>3.0.CO;2-S
10.1007/s10549-005-1040-1
10.1016/j.joca.2005.08.005
10.1164/ajrccm.157.6.9609040
10.1083/jcb.200502013
ContentType Journal Article
Copyright COPYRIGHT 2014 BioMed Central Ltd.
Copyright © 2014 Joiner et al.; licensee BioMed Central Ltd. 2014 Joiner et al.; licensee BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2014 BioMed Central Ltd.
– notice: Copyright © 2014 Joiner et al.; licensee BioMed Central Ltd. 2014 Joiner et al.; licensee BioMed Central Ltd.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1186/ar4522
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

MEDLINE

CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1478-6362
1478-6354
EndPage R81
ExternalDocumentID oai_biomedcentral_com_ar4522
A540833425
10_1186_ar4522
24670222
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-5E
-5G
-A0
-BR
.GJ
0R~
23N
2WC
4.4
5GY
5VS
6J9
AAFWJ
AAJSJ
ACGFS
ACJQM
ACRMQ
ADBBV
ADINQ
ADUKV
AEGXH
AENEX
AHBYD
AHMBA
AHSBF
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BCNDV
BFQNJ
BMC
C24
C6C
CGR
CS3
CUY
CVF
DIK
E3Z
EBD
EBLON
ECM
EIF
EJD
EMOBN
F5P
GROUPED_DOAJ
GX1
HYE
HZ~
IAO
IHR
INH
INR
ITC
KQ8
NPM
O5R
O5S
O9-
PGMZT
PQQKQ
RBZ
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
U2A
WOQ
Z7U
AAYXX
CITATION
AFGXO
AFPKN
7X8
3V.
53G
7X7
88E
8FI
8FJ
ABUWG
ABVAZ
AFKRA
AFNRJ
AHYZX
BENPR
BPHCQ
BVXVI
C1A
CCPQU
FYUFA
HMCUK
M1P
PIMPY
PROAC
PSQYO
UKHRP
ZA5
ZGI
5PM
ID FETCH-LOGICAL-b483t-eef4331d7d1e746e3516c30b897aa312a8a8e495d4bc2e0dfb72248d10ad03553
IEDL.DBID RPM
ISSN 1478-6354
IngestDate Tue Sep 17 21:26:14 EDT 2024
Wed May 22 07:13:14 EDT 2024
Fri Oct 25 04:23:17 EDT 2024
Wed Aug 14 18:52:48 EDT 2024
Tue Aug 13 05:22:34 EDT 2024
Wed Oct 09 16:54:12 EDT 2024
Tue Oct 15 23:53:51 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b483t-eef4331d7d1e746e3516c30b897aa312a8a8e495d4bc2e0dfb72248d10ad03553
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060238/
PMID 24670222
PQID 1558523997
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4060238
biomedcentral_primary_oai_biomedcentral_com_ar4522
proquest_miscellaneous_1558523997
gale_infotracmisc_A540833425
gale_infotracacademiconefile_A540833425
crossref_primary_10_1186_ar4522
pubmed_primary_24670222
PublicationCentury 2000
PublicationDate 2014-03-27
PublicationDateYYYYMMDD 2014-03-27
PublicationDate_xml – month: 03
  year: 2014
  text: 2014-03-27
  day: 27
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Arthritis research & therapy
PublicationTitleAlternate Arthritis Res Ther
PublicationYear 2014
Publisher BioMed Central Ltd
BioMed Central
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
References 16759941 - Prog Histochem Cytochem. 2006;40(3):135-63
18821697 - Arthritis Rheum. 2008 Oct;58(10):3071-80
11037873 - Arthritis Rheum. 2000 Oct;43(10):2143-51
18924142 - J Orthop Res. 2009 Mar;27(3):347-52
21604062 - Rheumatol Int. 2012 Aug;32(8):2301-6
23204325 - Mol Endocrinol. 2013 Jan;27(1):162-71
23555785 - PLoS One. 2013;8(3):e59798
19819718 - Trends Endocrinol Metab. 2009 Dec;20(10):517-24
22102283 - J Biol Chem. 2012 Jan 2;287(1):712-22
21736944 - Osteoarthritis Cartilage. 2011 Sep;19(9):1142-9
22392533 - Arthritis Rheum. 2012 Jun;64(6):1697-707
16242352 - Osteoarthritis Cartilage. 2006 Jan;14(1):13-29
21542005 - J Bone Miner Res. 2011 May;26(5):1022-34
22231237 - Nat Rev Rheumatol. 2012 Feb;8(2):77-89
18046415 - Nature. 2007 Nov 29;450(7170):741-4
12925580 - Development. 2003 Oct;130(19):4515-25
17322455 - Endocr Rev. 2007 May;28(3):284-96
19247731 - Clin Orthop Relat Res. 2009 Aug;467(8):1955-63
19710174 - Development. 2009 Oct;136(19):3347-56
20367117 - Connect Tissue Res. 2010 Oct;51(5):347-58
9620926 - Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1907-12
22387238 - Bone. 2012 Aug;51(2):249-57
17603291 - Exp Mol Med. 2007 Jun 30;39(3):367-75
18330928 - Dev Dyn. 2008 Aug;237(8):2013-20
12697730 - J Clin Invest. 2003 Apr;111(8):1120-2
22361237 - Osteoarthritis Cartilage. 2012 Jun;20(6):562-71
18543257 - J Cell Physiol. 2008 Nov;217(2):409-22
15492241 - Cancer Res. 2004 Oct 15;64(20):7241-4
16247031 - J Cell Biol. 2005 Oct 24;171(2):337-48
16087873 - Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11740-5
22975324 - Dev Cell. 2012 Sep 11;23(3):547-59
22393153 - J Immunol. 2012 Apr 1;188(7):3513-21
22197997 - Bone. 2012 Aug;51(2):212-7
15952054 - Breast Cancer Res Treat. 2005 Jun;91(3):207-15
21887704 - J Bone Miner Res. 2011 Nov;26(11):2622-33
15910752 - Biochem Biophys Res Commun. 2005 Jul 1;332(2):482-6
17351343 - Cell Cycle. 2007 Mar 1;6(5):507-13
16134726 - Scand J Rheumatol. 2005 May-Jun;34(3):204-11
10749885 - J Biol Chem. 2000 Jun 9;275(23):17838-47
17968906 - Arthritis Rheum. 2007 Nov;56(11):3693-705
23756208 - Osteoarthritis Cartilage. 2013 Oct;21(10):1576-85
19097796 - Knee. 2009 Aug;16(4):239-44
23426968 - Am J Physiol Cell Physiol. 2013 May 1;304(9):C905-17
19823173 - Lab Invest. 2010 Jan;90(1):20-30
19643414 - J Biomech. 2009 Aug 25;42(12):1825-33
18687272 - Rheum Dis Clin North Am. 2008 Aug;34(3):561-71
16242972 - Osteoarthritis Cartilage. 2006 Feb;14(2):114-9
16829981 - Nat Rev Mol Cell Biol. 2006 Jul;7(7):505-16
19519926 - Arthritis Res Ther. 2009;11(3):224
22575362 - Bone. 2012 Jul;51(1):131-41
18056042 - Ann N Y Acad Sci. 2007 Nov;1117:175-80
15896985 - Osteoarthritis Cartilage. 2005 Jul;13(7):632-41
CR Scanzello (4169_CR8) 2012; 51
KP Pritzker (4169_CR35) 2006; 14
MB Goldring (4169_CR3) 2009; 11
CD Swanson (4169_CR19) 2012; 188
A Makkinje (4169_CR47) 2000; 275
YW Zhang (4169_CR26) 2005; 102
N Jin (4169_CR31) 2009; 136
YW Zhang (4169_CR24) 2007; 6
JE Tapper (4169_CR49) 2009; 42
J Borrelli Jr (4169_CR4) 2009; 27
A Bhowmik (4169_CR40) 2013; 8
SE Usmani (4169_CR16) 2012; 51
X Zhang (4169_CR25) 2007; 450
J Pan (4169_CR33) 2012; 51
X Zhang (4169_CR14) 2011; 26
K Kuroki (4169_CR30) 2011; 19
C Velasquillo (4169_CR27) 2007; 1117
RG Mateescu (4169_CR48) 2005; 332
SF Lo (4169_CR17) 2012; 32
MR Schneider (4169_CR11) 2009; 20
S Tracy (4169_CR41) 2004; 64
T Yi (4169_CR36) 2008; 217
S Hopkins (4169_CR42) 2012; 23
A Citri (4169_CR10) 2006; 7
X Zhang (4169_CR13) 2011; 26
M Sibilia (4169_CR15) 2003; 130
GY Hur (4169_CR46) 2007; 39
PF Sumariwalla (4169_CR20) 2008; 58
RF Loeser (4169_CR1) 2012; 64
H Lorenz (4169_CR2) 2006; 40
SR McGlashan (4169_CR7) 2008; 237
S Iacob (4169_CR23) 2010; 51
JS Rush (4169_CR39) 2012; 287
JM Kreider (4169_CR50) 2009; 467
S Hashimoto (4169_CR5) 2012; 20
NH Bell (4169_CR37) 2003; 111
SR Goldring (4169_CR52) 2008; 34
J Xu (4169_CR44) 2005; 91
G Pante (4169_CR38) 2005; 171
LJ Sandell (4169_CR6) 2012; 8
CT Appleton (4169_CR21) 2010; 90
HF Turk (4169_CR51) 2013; 304
CT Appleton (4169_CR22) 2007; 56
DM Joiner (4169_CR34) 2013; 21
EM Gravallese (4169_CR9) 2000; 43
S Kamekura (4169_CR32) 2005; 13
YC Chen (4169_CR43) 2013; 27
F Nelson (4169_CR29) 2006; 14
M Amishima (4169_CR45) 1998; 157
H Louboutin (4169_CR28) 2009; 16
CJ Xian (4169_CR12) 2007; 28
AL Hallbeck (4169_CR18) 2005; 34
References_xml – volume: 11
  start-page: 224
  year: 2009
  ident: 4169_CR3
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar2592
  contributor:
    fullname: MB Goldring
– volume: 90
  start-page: 20
  year: 2010
  ident: 4169_CR21
  publication-title: Lab Invest
  doi: 10.1038/labinvest.2009.111
  contributor:
    fullname: CT Appleton
– volume: 16
  start-page: 239
  year: 2009
  ident: 4169_CR28
  publication-title: Knee
  doi: 10.1016/j.knee.2008.11.004
  contributor:
    fullname: H Louboutin
– volume: 14
  start-page: 13
  year: 2006
  ident: 4169_CR35
  publication-title: Osteoarthritis Cartilage
  doi: 10.1016/j.joca.2005.07.014
  contributor:
    fullname: KP Pritzker
– volume: 450
  start-page: 741
  year: 2007
  ident: 4169_CR25
  publication-title: Nature
  doi: 10.1038/nature05998
  contributor:
    fullname: X Zhang
– volume: 237
  start-page: 2013
  year: 2008
  ident: 4169_CR7
  publication-title: Dev Dyn
  doi: 10.1002/dvdy.21501
  contributor:
    fullname: SR McGlashan
– volume: 27
  start-page: 347
  year: 2009
  ident: 4169_CR4
  publication-title: J Orthop Res
  doi: 10.1002/jor.20760
  contributor:
    fullname: J Borrelli Jr
– volume: 34
  start-page: 204
  year: 2005
  ident: 4169_CR18
  publication-title: Scand J Rheumatol
  doi: 10.1080/03009740510017715
  contributor:
    fullname: AL Hallbeck
– volume: 51
  start-page: 212
  year: 2012
  ident: 4169_CR33
  publication-title: Bone
  doi: 10.1016/j.bone.2011.11.030
  contributor:
    fullname: J Pan
– volume: 287
  start-page: 712
  year: 2012
  ident: 4169_CR39
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M111.294470
  contributor:
    fullname: JS Rush
– volume: 58
  start-page: 3071
  year: 2008
  ident: 4169_CR20
  publication-title: Arthritis Rheum
  doi: 10.1002/art.23885
  contributor:
    fullname: PF Sumariwalla
– volume: 39
  start-page: 367
  year: 2007
  ident: 4169_CR46
  publication-title: Exp Mol Med
  doi: 10.1038/emm.2007.41
  contributor:
    fullname: GY Hur
– volume: 51
  start-page: 249
  year: 2012
  ident: 4169_CR8
  publication-title: Bone
  doi: 10.1016/j.bone.2012.02.012
  contributor:
    fullname: CR Scanzello
– volume: 188
  start-page: 3513
  year: 2012
  ident: 4169_CR19
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1102693
  contributor:
    fullname: CD Swanson
– volume: 332
  start-page: 482
  year: 2005
  ident: 4169_CR48
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2005.04.144
  contributor:
    fullname: RG Mateescu
– volume: 64
  start-page: 1697
  year: 2012
  ident: 4169_CR1
  publication-title: Arthritis Rheum
  doi: 10.1002/art.34453
  contributor:
    fullname: RF Loeser
– volume: 23
  start-page: 547
  year: 2012
  ident: 4169_CR42
  publication-title: Dev Cell
  doi: 10.1016/j.devcel.2012.08.001
  contributor:
    fullname: S Hopkins
– volume: 28
  start-page: 284
  year: 2007
  ident: 4169_CR12
  publication-title: Endocr Rev
  doi: 10.1210/er.2006-0049
  contributor:
    fullname: CJ Xian
– volume: 27
  start-page: 162
  year: 2013
  ident: 4169_CR43
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2012-1174
  contributor:
    fullname: YC Chen
– volume: 304
  start-page: C905
  year: 2013
  ident: 4169_CR51
  publication-title: Am J Physiol Cell Physiol
  doi: 10.1152/ajpcell.00379.2012
  contributor:
    fullname: HF Turk
– volume: 64
  start-page: 7241
  year: 2004
  ident: 4169_CR41
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-04-1905
  contributor:
    fullname: S Tracy
– volume: 7
  start-page: 505
  year: 2006
  ident: 4169_CR10
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm1962
  contributor:
    fullname: A Citri
– volume: 102
  start-page: 11740
  year: 2005
  ident: 4169_CR26
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0505171102
  contributor:
    fullname: YW Zhang
– volume: 13
  start-page: 632
  year: 2005
  ident: 4169_CR32
  publication-title: Osteoarthritis Cartilage
  doi: 10.1016/j.joca.2005.03.004
  contributor:
    fullname: S Kamekura
– volume: 26
  start-page: 1022
  year: 2011
  ident: 4169_CR13
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.295
  contributor:
    fullname: X Zhang
– volume: 51
  start-page: 131
  year: 2012
  ident: 4169_CR16
  publication-title: Bone
  doi: 10.1016/j.bone.2012.04.012
  contributor:
    fullname: SE Usmani
– volume: 111
  start-page: 1120
  year: 2003
  ident: 4169_CR37
  publication-title: J Clin Invest
  doi: 10.1172/JCI18358
  contributor:
    fullname: NH Bell
– volume: 51
  start-page: 347
  year: 2010
  ident: 4169_CR23
  publication-title: Connect Tissue Res
  doi: 10.3109/03008200903427695
  contributor:
    fullname: S Iacob
– volume: 1117
  start-page: 175
  year: 2007
  ident: 4169_CR27
  publication-title: Ann N Y Acad Sci
  doi: 10.1196/annals.1402.019
  contributor:
    fullname: C Velasquillo
– volume: 20
  start-page: 517
  year: 2009
  ident: 4169_CR11
  publication-title: Trends Endocrinol Metab
  doi: 10.1016/j.tem.2009.06.008
  contributor:
    fullname: MR Schneider
– volume: 26
  start-page: 2622
  year: 2011
  ident: 4169_CR14
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.502
  contributor:
    fullname: X Zhang
– volume: 32
  start-page: 2301
  year: 2012
  ident: 4169_CR17
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-011-1961-4
  contributor:
    fullname: SF Lo
– volume: 467
  start-page: 1955
  year: 2009
  ident: 4169_CR50
  publication-title: Clin Orthop Relat Res
  doi: 10.1007/s11999-009-0751-8
  contributor:
    fullname: JM Kreider
– volume: 42
  start-page: 1825
  year: 2009
  ident: 4169_CR49
  publication-title: J Biomech
  doi: 10.1016/j.jbiomech.2009.05.034
  contributor:
    fullname: JE Tapper
– volume: 275
  start-page: 17838
  year: 2000
  ident: 4169_CR47
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M909735199
  contributor:
    fullname: A Makkinje
– volume: 136
  start-page: 3347
  year: 2009
  ident: 4169_CR31
  publication-title: Development
  doi: 10.1242/dev.032979
  contributor:
    fullname: N Jin
– volume: 40
  start-page: 135
  year: 2006
  ident: 4169_CR2
  publication-title: Prog Histochem Cytochem
  doi: 10.1016/j.proghi.2006.02.003
  contributor:
    fullname: H Lorenz
– volume: 34
  start-page: 561
  year: 2008
  ident: 4169_CR52
  publication-title: Rheum Dis Clin North Am
  doi: 10.1016/j.rdc.2008.07.001
  contributor:
    fullname: SR Goldring
– volume: 130
  start-page: 4515
  year: 2003
  ident: 4169_CR15
  publication-title: Development
  doi: 10.1242/dev.00664
  contributor:
    fullname: M Sibilia
– volume: 21
  start-page: 1576
  year: 2013
  ident: 4169_CR34
  publication-title: Osteoarthritis Cartilage
  doi: 10.1016/j.joca.2013.05.019
  contributor:
    fullname: DM Joiner
– volume: 6
  start-page: 507
  year: 2007
  ident: 4169_CR24
  publication-title: Cell Cycle
  doi: 10.4161/cc.6.5.3928
  contributor:
    fullname: YW Zhang
– volume: 20
  start-page: 562
  year: 2012
  ident: 4169_CR5
  publication-title: Osteoarthritis Cartilage
  doi: 10.1016/j.joca.2012.01.022
  contributor:
    fullname: S Hashimoto
– volume: 217
  start-page: 409
  year: 2008
  ident: 4169_CR36
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.21511
  contributor:
    fullname: T Yi
– volume: 8
  start-page: 77
  year: 2012
  ident: 4169_CR6
  publication-title: Nat Rev Rheumatol
  doi: 10.2174/157339712802083795
  contributor:
    fullname: LJ Sandell
– volume: 56
  start-page: 3693
  year: 2007
  ident: 4169_CR22
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22968
  contributor:
    fullname: CT Appleton
– volume: 8
  start-page: e59798
  year: 2013
  ident: 4169_CR40
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0059798
  contributor:
    fullname: A Bhowmik
– volume: 19
  start-page: 1142
  year: 2011
  ident: 4169_CR30
  publication-title: Osteoarthritis Cartilage
  doi: 10.1016/j.joca.2011.06.007
  contributor:
    fullname: K Kuroki
– volume: 43
  start-page: 2143
  year: 2000
  ident: 4169_CR9
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(200010)43:10<2143::AID-ANR1>3.0.CO;2-S
  contributor:
    fullname: EM Gravallese
– volume: 91
  start-page: 207
  year: 2005
  ident: 4169_CR44
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-005-1040-1
  contributor:
    fullname: J Xu
– volume: 14
  start-page: 114
  year: 2006
  ident: 4169_CR29
  publication-title: Osteoarthritis Cartilage
  doi: 10.1016/j.joca.2005.08.005
  contributor:
    fullname: F Nelson
– volume: 157
  start-page: 1907
  year: 1998
  ident: 4169_CR45
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.157.6.9609040
  contributor:
    fullname: M Amishima
– volume: 171
  start-page: 337
  year: 2005
  ident: 4169_CR38
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200502013
  contributor:
    fullname: G Pante
SSID ssj0022924
Score 2.213983
Snippet Ligament and meniscal damage can cause joint disease. Arthritic joints contain increased amounts of epidermal growth factor receptor (EGFR) protein, and...
Abstract Introduction Ligament and meniscal damage can cause joint disease. Arthritic joints contain increased amounts of epidermal growth factor receptor...
Introduction Ligament and meniscal damage can cause joint disease. Arthritic joints contain increased amounts of epidermal growth factor receptor (EGFR)...
INTRODUCTIONLigament and meniscal damage can cause joint disease. Arthritic joints contain increased amounts of epidermal growth factor receptor (EGFR)...
INTRODUCTION: Ligament and meniscal damage can cause joint disease. Arthritic joints contain increased amounts of epidermal growth factor receptor (EGFR)...
SourceID pubmedcentral
biomedcentral
proquest
gale
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage R81
SubjectTerms Animals
Arthritis
Arthritis, Experimental - etiology
Arthritis, Experimental - metabolism
Arthritis, Experimental - pathology
Blotting, Western
Bones
Density
Enzyme-Linked Immunosorbent Assay
Intracellular Signaling Peptides and Proteins - metabolism
Knee Injuries - complications
Knee Injuries - metabolism
Knee Injuries - pathology
Knee Joint
Ligaments - injuries
Mice
Mice, Knockout
Osteoarthritis - etiology
Osteoarthritis - metabolism
Osteoarthritis - pathology
Reverse Transcriptase Polymerase Chain Reaction
Tibial Meniscus Injuries
X-Ray Microtomography
SummonAdditionalLinks – databaseName: BiomedCentral
  dbid: RBZ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkKpeqpY-CFBwpUo9RU1ix_YeF1SEkOBUJNRL5FfaoCVBbPbQ_8CPZiYJW4x66i3JONlsxuP5xvZ8A_CFK17O0HWkiA0wQBGuTrWpZRpojarMubRDhtz5hTy9FGdX5dUGsH-v4OdafjN3RPr9ArYKIlKhePzo5zqkKmZj2VqBsRC6TjFVD_p737M89kXkfp4Pwk-8ULxD8onLOXkDryesyOajct_CRmi34eX5tBr-Du7nzqHXILIHz0zrWdMSBlzi2XXXtD3z5gaHC7zM_pBRMyo9z2jmlY08ICihvIZxVpZ1NTboO-xRKQbqK9fYRWB4FphkQylxtmh-GZpNHH4MD5qlWy3xIdeomPdwefL9x_FpOlVXSK3QvE9DqClbyiufByVk4GUuHc-sniljeF4YbXTA8MkL64qQ-doqdPfa55nxGaIU_gE2264NO8ByqTLhZY3wYyYyLoy1GYZ95UAO58oygSJSQnU7MmlUxG0dS9DMqlFzCRw-amrdfohYtFy3-EoKrMgU8WZnpowCfCkitarmiEY15zgqJbAftUQTcpH482MXqEhE-87a0K2WFaItXVL6r0rg49gl1i9ToI-hcDkBFXWW6N_Fkrb5PTB4I4oirLT7P99lD14haBO0D65Q-7DZ363CJwRGvT0YbOMBeGsQQw
  priority: 500
  providerName: BioMedCentral
Title Accelerated and increased joint damage in young mice with global inactivation of mitogen-inducible gene 6 after ligament and meniscus injury
URI https://www.ncbi.nlm.nih.gov/pubmed/24670222
https://search.proquest.com/docview/1558523997
http://dx.doi.org/10.1186/ar4522
https://pubmed.ncbi.nlm.nih.gov/PMC4060238
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF61PSAuiDeGEhYJiZMb27t-5BgqqgIKQohKFRdrXy6uErsizoH_wI_mm7Ud1T1yiezM2llnZnbmW8-DsXciF-kCpiOEbwCAIk0VFqrKQkfvqNJYZNpnyK2-ZucX8vNlennA0jEXxgftG12fNOvNSVP_8rGVNxszH-PE5t9WpzBCZGrmh-wQAjpC9AFlJYu-k60EPII1lUNDobjIcA-qH071f7E8ENK5k-W-nhinu0v0LRs1jZ-8ZZDOHrIHgyfJl_2MH7ED1zxm91bDu_In7O_SGNgUKgVhuWosrxvyELc4u27rpuNWbbCY4Gv-h1SeU2N6TvuyvK8SAgplPfR7trytMKBrIW8hYPzO1HrtOM4cz7hvNM7X9ZWivUb_Yziot2a3xU2uwban7OLs44_T83DovRBqWYgudK6iXCqb29jlMnMijTMjIl0scqVEnKhCFQ7gykptEhfZSudwBgobR8pG8GHEM3bUtI17wXiM_1rarIJzspCRkErrCKAw9aXjTJoGLJkwobzp62yUVPl6SoESlj0TA_Zm5NR-vMczRbYf8Z4YWJKi4mKjhnwDTIpKXpVL-KqFEFizAnY8GQkFMxPy21EESiJRVFrj2t22hC9WpJQcnAfseS8S-8mMIhawfCIsk6ebUiDuvr73IN4v__vKV-w-_DpJoXJJfsyOut879xq-U6dnQA2fvsz8zgM-v3_4OfPa8w-Vmh6e
link.rule.ids 108,230,315,730,783,787,867,888,24949,27936,27937,53804,53806,76146,76147
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VIgEX3lBDoYuExMmJ7V0_cowqqgBNxaFFvVn7Mrgk66qxD_Ab-NHM-BHVucEtzqwfK3878816HgDvecrjGZoOH7kBOihCF34mi8S39I0qDnmi2gy55VmyuBCfL-PLPYiHXJg2aF-rcuJW64krf7SxlddrPR3ixKZfl8dohMjUTO_AXVyvgRic9N7PimZdL1uBDhLaU9G3FAqzBK9CFcSpAjAqCPJ1dvLcVyPztKukb1mpcQTlLZN08gi-DZPpIlF-TppaTfTvnTqP_zzbx_CwJ6ls3omfwJ51T-Hesv8M_wz-zLVGc0VVJgyTzrDSEfnc4NFVVbqaGblGPYV_s1-kTRj1vGe05cu6AiQooYSKbjuYVQUOqCuEsl860-hSrSzDI8sS1vYwZ6vyu6RtzPZm-KPc6GaDF7lCRDyHi5OP58cLv2_r4CuR8dq3tqA0LZOa0KYisTwOE80Dlc1SKXkYyUxmFv02I5SObGAKlSLPyEwYSBMgPeIvYN9Vzh4AC_ElCpMUyHtmIuBCKhWgvxm3Vel0HHsQjd5uft2V8MipqPZYgus779DhwdEAge341lXKku2ID4SMnHQAnqxln8qAD0XVtPI50uCMc1SHHhyORuLa1SPxuwFbOYko4M3ZqtnkSPOymPKOUw9edljbPsyAXQ_SEQpHsxtLEFtt6fAeS6_--8wjuL84X57mp5_OvryGB0gfBUXkRekh7Nc3jX2DFK1Wb9sF-RfDnD2O
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BkSou5Q2GQhcJiZMT27teb45RISqPVD1QqeJi7cvFJdlEjX2A38CPZsaPKM6xtzgzfqz87cw365lZQj6wjKUTcB0hcAMIULgpQqkKETr8RpXGTOimQm5-Ls4u-der9Gpnq68mad_ocuQXy5EvfzW5leulGfd5YuOL-Sk4IXQ147UtxvfJA5izkegD9S7WSibtfrYcgiTwqbzbViiWAq6EXcSxCzAYCYx39mrdFwMXtW-odzzVMItyxy3NHpGf_YDabJTfo7rSI_N3r9fjnUb8mBx1ZJVOW5Un5J7zT8nhvPsc_4z8mxoDbgu7TViqvKWlRxK6gaObVekratUS7BX8Tf-gVaFLMEsUl35p24gEJFhY0S4L01UBCtUKIB2W3tam1AtH4chRQZu9zOmivFa4nNncDH6UG1Nv4CI3gIzn5HL2-cfpWdht7xBqLlkVOldguZbNbOwyLhxLY2FYpOUkU4rFiZJKOojfLNcmcZEtdAZ8Q9o4UjYCmsRekAO_8u4VoTG8SG5FAfxnwiPGldYRxJ1p053OpGlAksEbztdtK48cm2sPJTDP8xYhATnpYbDVb0ImKbYaHxEdOdoCONmorqQBHgq7auVToMOSMTCLATkeaMIcNgPx-x5fOYow8c27Vb3Jge7JFOuPs4C8bPG2fZgevwHJBkgcjG4oAXw1LcQ7PL2-85kn5PDi0yz__uX82xvyEFgkx8S8JDsmB9Vt7d4CU6v0u2ZO_geHAEAO
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Accelerated+and+increased+joint+damage+in+young+mice+with+global+inactivation+of+mitogen-inducible+gene+6+after+ligament+and+meniscus+injury&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Joiner%2C+Danese+M&rft.au=Less%2C+Kennen+D&rft.au=Van+Wieren%2C+Emily+M&rft.au=Zhang%2C+Yu-Wen&rft.date=2014-03-27&rft.eissn=1478-6362&rft.volume=16&rft.issue=2&rft.spage=R81&rft_id=info:doi/10.1186%2Far4522&rft_id=info%3Apmid%2F24670222&rft.externalDocID=24670222
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6354&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6354&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6354&client=summon